paper-with-me

Papers

Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates

2021-05-07 · Jenna Bilbrey, Logan Ward, Sutanay Choudhury, Neeraj Kumar, Ganesh Sivaraman

We examine a pair of graph generative models for the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. Due to a sense of urgency, we chose well-validated models with unique strengths: an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity and a reinforcement learning algorithm that generates highly novel molecules. During generation, we explore optimization toward several design targets to balance druglikeness, synthetic accessability, and anti-SARS activity based on \icfifty. This generative framework\footnote{https://github.com/exalearn/covid-drug-design} will accelerate drug discovery in future pandemics through the high-throughput generation of targeted therapeutic candidates.

📄 PDF Abstract BibTeX arXiv:2105.10489

Code (1)

exalearn/covid-drug-design 공식 구현 pytorch

Tasks

Drug DesignDrug Discoveryreinforcement-learningReinforcement Learning (RL)

Similar Papers 제목 키워드 기반

Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates

2020-05-06 · Tim Cofala, Lars Elend, Philip Mirbach, Jonas Prellberg 외

Computational drug design based on artificial intelligence is an emerging research area. At the time of writing this paper, the world suffers from an outbreak of the coronavirus SARS-CoV-2. A promising way to stop the vi…

Drug Design

Drug Repurposing Targeting COVID-19 3CL Protease using Molecular Docking and Machine Learning Regression Approach

2023-05-25 · Imra Aqeel, Abdul Majid

The COVID-19 pandemic has initiated a global health emergency, with an exigent need for effective cure. Progressively, drug repurposing is emerging a promise solution as it saves the time, cost and labor. However, the nu…

Molecular Dockingregression

A small molecule drug candidate targeting SARS-CoV-2 main protease

2020-06-17

A new coronavirus identified as SARS-CoV-2 virus has brought the world to a state of crisis, causing a major pandemic, claiming more than 433,000 lives and instigating major financial damage to the global economy. Despit…

BlockingDrug DiscoveryTranslation

High-Throughput Virtual Screening of 4487 flavonoids: New insights on the structural inhibition of SARS-CoV-2 Main Protease

2020-08-30 · Gabriel M. Jiménez-Avalos, Ana P. Vargas-Ruiz, Nicolás E. Delgado-Pease, Gustavo E. Olivos-Ramirez 외

COVID-19 presents a great threat to public health worldwide and the infectious agent SARS-CoV-2 is currently the target of much research aiming at inhibition. The virus' main protease is a dimeric enzyme that has only re…

Carica papaya Leaf Extract Inhibits SARS-CoV-2 Main Proteases but not Human TMPRSS2: An In-vitro and In-silico Study

2022-12-01 · Maywan Hariono, Irwan Hidayat, Ipang Djunarko, Jeffry Julianus 외

Carica papaya (CP) leaf is long known for its traditional pharmacological effects against dengue virus and malaria. Therefore, CP could also be a potential solution for the treatment of other infectious diseases, such as…